Head-to-head evidence comparison — which supplement is right for you?
Choline wins 1 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
250-500mg daily (varies by form)
Morning or with meals, Alpha-GPC before cognitive tasks
Alpha-GPC or CDP-Choline (Citicoline)
100-200mg daily
Morning with food, Can be divided into two doses
Pycnogenol (standardized extract)
2-4 weeks
4-8 weeks
1-2 weeks
With high doses
4-8 weeks
6-12 weeks
4-8 weeks
Initial use
Association of choline and betaine with the risk of cardiovascular disease and all-cause mortality: Meta-analysis
European journal of clinical investigation (2023) · Meta analysis · n=33009
Random-effects model results showed that highest versus lowest quantile of circulating choline concentrations were associated with the risk of CVD (RR = 1.29, 95% CI: 1.04-1.61) and all-cause mortality (RR = 1.62, 95% CI: 1.12-2.36).
Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trial
The Lancet. Oncology (2025) · Rct · n=198
To our knowledge, this is the first randomised trial for metachronous PET-detected nodal recurrences comparing two local treatment approaches (MDT and ENRT) in combination with 6 months of androgen deprivation therapy.
Higher dietary choline intake is associated with increased risk of all-cause and cause-specific mortality: A systematic review and dose-response meta-analysis of cohort studies
Nutrition research (New York, N.Y.) (2024) · Meta analysis · n=482778
This study showed that each 100 mg/day increment in choline consumption was significantly associated with a 6% and 11% higher risk of all-cause and cardiovascular disease mortality respectively.
Phlebotonics for venous insufficiency
The Cochrane database of systematic reviews (2020) · Meta analysis · n=7690
Pooled data suggest that phlebotonics probably increase adverse events slightly, compared to placebo (RR 1.14, 95% CI 1.02 to 1.27; 37 studies; 5789 participants; moderate-certainty evidence).
Pine bark (Pinus spp.) extract for treating chronic disorders
The Cochrane database of systematic reviews (2020) · Meta analysis · n=1641
In a mixed group of participants with type 1 and type 2 DM we do not know whether pine bark extract decreases HbA1c (MD -0.20 %, 95% CI -1.83 to 1.43; one study; 67 participants; very low-certainty evidence).
Effect of pycnogenol supplementation on blood pressure: A systematic review and meta-analysis of clinical trials
Phytotherapy research : PTR (2020) · Meta analysis · n=922
Pooled analysis suggested that pycnogenol supplementation can reduced systolic blood pressure (SBP) of (-3.22 mmHg; 95% CI [-5.52, -0.92]) and diastolic blood pressure (DBP; -1.91 mmHg; 95% CI [-3.64, -0.18]).
Choline has a higher evidence score (9/10 vs 9/10) and wins in 1 of 3 categories.
For reduce inflammation, Choline has a higher relevance score (85 vs 75).
No known interactions between Choline and Pine Bark Extract have been documented in our database. However, always consult a healthcare provider before combining supplements.